Tumor cells

Thawing Protocol

Cell Line Catalog (Volume 2)

T1249 ZR-75-1 Cells

ZR-75-1 Cells (T1249) by MBP are an estrogen-dependent human breast cancer cell line expressing estrogen and progesterone receptors. Used for hormone-responsive breast cancer research and drug screening. Adherent epithelial, mammary. PDT 80h, split ratio 1:4–1:6. BSL II. 1&times;106 cells / 1.0 mL, frozen. MTA required.

Immortalized Cells

Subculturing Protocol

Freezing Protocol

T2009 MITC Treated Immortalized Mouse Embryonic Fibroblast Feeder Cells

T2009 MITC Treated Immortalized MEF Feeder Cells are mitomycin C-inactivated immortalized mouse embryonic fibroblasts providing a consistent, senescence-free feeder layer for ES and iPSC culture. Supplied by ABM as 1&times;106 cells/1.0 ml, frozen; BSL-2; RUO. MTA required.

T2017 MITC Inactivated Rat Embryonic Fibroblast (REF) Feeder Cells

T2017 MITC Inactivated REF Feeder Cells are mitomycin C-inactivated rat embryonic fibroblasts that outperform MEF feeder cells for human iPSC reprogramming and ES/iPS cell long-term culture, with no weekend medium change required. Supplied by ABM as 1&times;106 cells/1.0 ml, frozen; RUO. MTA required.

T2018 Transdifferentiated Mesenchymal Stem Cells

T2018 Transdifferentiated Mesenchymal Stem Cells are MSC that have undergone directed transdifferentiation, providing a model for lineage conversion, cell fate plasticity, and regenerative biology research. Supplied by ABM as 1&times;106 cells/1.0 ml, frozen; RUO. MTA required.

T2019 MEF-iPSC

T2019 MEF-iPSC are mouse iPSC generated from C57/BL6 MEF via lentiviral OCT4, SOX2, MYC, and KLF4 reprogramming, forming compact colonies with distinct borders. Supplied by ABM as 1&times;106 cells/1.0 ml, frozen; BSL-2; RUO. MTA required.

T2020 REF-iPSC

T2020 REF-iPSC are rat induced pluripotent stem cells derived from rat embryonic fibroblasts, forming compact colonies with distinct borders. Requires inactivated REF feeder cells (T2017) and Rat iPSC Culture Medium (TM021). Supplied by ABM as 1&times;106 cells/1.0 ml, frozen; BSL-2; RUO. MTA required.

T2021 KLF4 Positive Hela Cell Line

T2021 KLF4 Positive HeLa Cell Line is a HeLa-derived human cervical carcinoma cell line stably expressing KLF4 transcription factor, supplied by ABM as 1&times;106 cells/1.0 ml, frozen. BSL-2; research use only. MTA required.

T2022 LIN28 Positive Hela Cells

T2022 LIN28 Positive HeLa Cells are HeLa-derived human cervical carcinoma cells stably expressing LIN28, used for let-7 regulation, RNA-binding protein biology, cancer stemness, and reprogramming factor research. Supplied by ABM as 1&times;106 cells/1.0 ml, frozen; BSL-2; RUO. MTA required.

T2023 Myc Positive Hela Cells

T2023 MYC Positive HeLa Cells are HeLa-derived human cervical carcinoma cells stably expressing MYC (c-Myc), used for oncogene functional studies, MYC-driven transcription, cell proliferation, and reprogramming factor biology. Supplied by ABM as 1&times;106 cells/1.0 ml, frozen; BSL-2; RUO. MTA required.

T2024 Nanog Positive Hela Cells

T2024 NANOG Positive HeLa Cells are HeLa-derived human cervical carcinoma cells stably expressing NANOG, used for cancer stemness, pluripotency transcription factor, and drug resistance research. Supplied by ABM as 1&times;106 cells/1.0 ml, frozen; BSL-2; RUO. MTA required.

T2025 OCT4 Positive Hela Cells

T2025 OCT4 Positive HeLa Cells are HeLa-derived human cervical carcinoma cells stably expressing OCT4 (POU5F1), used for stemness, pluripotency factor, and gene regulation research. Supplied by ABM as 1&times;106 cells/1.0 ml, frozen; BSL-2; RUO. MTA required.

T2026 SOX2 Positive Hela Cells

T2026 SOX2 Positive HeLa Cells are HeLa-derived human cervical carcinoma cells stably expressing SOX2, used for cancer stemness, pluripotency factor, and gene regulation research. Supplied by ABM as 1&times;106 cells/1.0 ml, frozen; BSL-2; RUO. MTA required.